share_log

嘉应制药:关于受让广东华清园生物科技有限公司45%股权的公告

Jiaying Pharmaceutical: Announcement on the transfer of 45% of Guangdong Huaqingyuan Biotechnology Co., Ltd.

SZSI ·  Jan 2, 2014 00:00

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.